DOI:
10.1055/s-00034913
Phlebologie
LinksClose Window
References
Pollack CV jr., Reilly PA, van Ryn J. et al.
Idarucizumab for Dabigatran Reversal – Full Cohort Analysis.
N Engl J Med 2017;
377: 431-441
DOI: 10.1056/NEJMoa1707278. (PMID: 28693366)
We do not assume any responsibility for the contents of the web pages of other providers.